Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Website URL
Similar Companies1000
Kymera Therapeutics
Kymera Therapeutics is a biotech company specializing in targeted protein degradation.
Sector
Subsector
Keywords
Location
total rounds
total raised
Biond Biologics
Biond Biologics is an Israeli biotech company focused on cancer immunotherapy and autoimmune disorders.
Sector
Subsector
Location
total rounds
total raised
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company that develops innovative targeted biologic drugs using its proprietary FHAB™ technology.
Sector
Subsector
Keywords
Location
total rounds
total raised
Orum Therapeutics
Orum Therapeutics is a private biotech company developing therapeutic antibodies to target cytosolic proteins for cancer and rare diseases.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds4
Number of Funding Rounds
Money Raised
Their latest funding was raised on 28.11.2023. Their latest investor Cowen Healthcare Investments. Their latest round Series B
Cowen Healthcare Investments
Cowen Healthcare Investments is a financial services firm offering asset management and investment banking.
Sector
Subsector
Location
count Of Investments
count Of Exists
Cowen Healthcare Investments
Cowen Healthcare Investments is a financial services firm offering asset management and investment banking.
Sector
Subsector
Location
count Of Investments
count Of Exists
Northpond Ventures
Northpond Ventures is a science-driven venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Cowen Healthcare Investments
Cowen Healthcare Investments is a financial services firm offering asset management and investment banking.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors10
Number of lead investors
Number of investors
Cowen Healthcare Investments
Cowen Healthcare Investments is a financial services firm offering asset management and investment banking.
Sector
Subsector
Location
count Of Investments
count Of Exists
HealthCap
HealthCap is a venture capital firm that invests in life sciences globally.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
BVF Partners
BVF Partners is a US-based venture capital firm that specializes in investing in small-cap biotechnology companies.
Sector
Subsector
Keywords
count Of Investments
People
Founders2
Susan Dillon
Sue Dillon, PhD, brings 30 years of experience in executive leadership roles at pharmaceutical and biotech companies to Aro Biotherapeutics. During her more than 16 year career at Johnson & Johnson, Sue led global Immunology R&D, and achieved numerous regulatory approvals for innovative antibody products for autoimmune diseases including REMICADE®, SIMPONI®, STELARA® and TREMFYA®. She also built a robust Immunology development portfolio through internal discovery and external licensing, and championed research into the emerging areas of the microbiome and immune repertoire profiling. Multi-disciplinary teams under Sue’s leadership were twice recognized with the Prix Galien Award for PROMACTA® and STELARA®, each first-in-class medicines. Sue received her PhD in Immunology from Thomas Jefferson University in Philadelphia and completed a postdoctoral fellowship in Immunology at Duke University. She was named by FierceBiotech as one of the “Top Women in Biotech” in 2013.
current job
organization founded
Susan Dillon
Karyn O’Neil
Karyn O’Neil has more than 30 years of experience in peptide, antibody and protein engineering. As the Venture Leader for Centyrex, a Johnson & Johnson Venture, Karyn focused on designer protein platform technologies. She is co-inventor on the Centyrin patents and has led the team advancing the Centyrin platform since its inception. She joined Centocor/Johnson & Johnson in 2001 where, prior to working on Centyrins, she held positions of increasing responsibility, ultimately becoming a Director of Antibody Therapeutics. There she played a leadership role in the discovery and optimization of multiple clinical candidates. Prior to Johnson & Johnson, Karyn was in the Applied Biotechnologies group at DuPont Pharmaceuticals. Karyn received her PhD from the University of Pennsylvania where she focused on protein engineering and protein biophysics. She has authored more than 55 publications and holds over 30 patents. Karyn also serves as an editor for Protein Engineering, Design and Selection.
current job
organization founded
Karyn O’Neil
Employee Profiles6
Derek Miller
Chief Business Officer & Head of Corporate Strategy
Karyn O’Neil
Co-founder and Chief Scientific Officer
Susan Dillon
Co-founder, President and Chief Executive Officer
Mark Laurenzi
Vice President of Finance and Operations
Activity
Recent News4
The graph reveals the ratio (%) of positive news articles in a chosen time range